https://www.marketscreener.com/quote/stock/ACTELION-9364986/news/Actelion-receives-approval-for-Uptravi-selexipag-for-the-treatment-of-pulmonary-arterial-hyperte-22050584/?utm_source=telegram&utm_medium=social&utm_campaign=share